Cardiol Therapeutics Inc.
CRDL
$1.39
$0.042.96%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/12/2026
-
TipRanks Financial Blog
5/7/2026
-
CNW Group - News Releases
5/7/2026
-
PR Newswire
4/28/2026
-
The Fly
4/28/2026
-
PR Newswire
4/28/2026
-
CNW Group - News Releases
4/21/2026
-
MarketBeat
4/20/2026
-
Newsfile Corp. - News Releases
4/18/2026
-
MarketBeat
4/15/2026
-
MarketBeat
Cardiol Therapeutics Showcases MAVERIC Phase III Trial and ARCHER Results in Barchart Live Interview
4/14/2026
-
TipRanks Financial Blog
4/14/2026
-
Newsfile Corp. - News Releases
4/10/2026
-
TipRanks Financial Blog
4/7/2026
-
MarketBeat
4/7/2026
-
MarketBeat
4/7/2026
-
TipRanks Financial Blog
4/6/2026
-
MarketBeat
4/5/2026
-
MarketBeat
4/3/2026
-
MarketBeat
4/1/2026
-
MarketBeat
4/1/2026
-
TipRanks Financial Blog
4/1/2026
-
Newsfile Corp. - News Releases
3/27/2026
-
MarketBeat
3/25/2026
-
MarketBeat
3/21/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, March 31, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
289 910 0850
Address
2265 Upper Middle Road East
Oakville, ON L6H 0G5
Oakville, ON L6H 0G5
Country
Year Founded
Business Description
Sector
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead...
more